Party insiders and backroom deals: One author on why we need to bring back old-time politics.
Guest Host: Susan Page
New cancer drugs are in the headlines: a promising treatment for colon cancer, and a dramatically effective treatment for leukemia. Guest host Susan Page talks with some of the doctors behind the development of these medications, and looks ahead to the future of cancer treatment.
- Dr. John Medelsohn president of the University of Texas M.D. Anderson Cancer Center
- Dr. Robert Wittes director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute/NIH
- Dr. Brian Druker director of the Leukemia Center at the Oregon Health and Science University
Most Recent Shows
With a now-likely U.K. exit from the EU, America’s relationship with a key intelligence and global trade ally will change. Please join us to discuss what the British vote means for the U.S. economy, the 2016 presidential campaign and global security.
Analysis of the Supreme Court's last decisions of the term and the impact of a vacant seat on the bench.
The world reacts to Brexit: European Union leaders plan for Great Britain's departure and investors brace for more uncertainty, as the U.S. considers economic and strategic implications.